Q&A with Christian John Lillis, CEO and Co-Founder of the Peggy Lillis Foundation
OpenDialog July 2026 – Issue Three
This month’s Q&A features the CEO and Co-Founder of the Peggy Lillis Foundation (PLF), the leading nonprofit organization that is building a nationwide C. diff (Clostridioides difficile) awareness movement by educating the public, empowering advocates, and shaping policy. He is Christian John Lillis, a tireless advocate, fundraiser and thought leader; and most critically, Christian is the eldest son of Peggy Lillis who died tragically at the age of 56 from C. diff.
Q&A with Dr. Cliff McDonald, CDC
OpenDialog March 2026 – Issue One
Patient outcomes may depend on science that’s moving faster than any of us can track. OpenBiome Foundation’s monthly newsletter cuts through the noise – delivering focused conversations with leading researchers and clinicians on the microbiome discoveries most relevant to your practice. The first edition features Dr. L. Clifford McDonald, MD, Associate Director for Science in the Division of Healthcare Quality Promotion (DHQP) at the Centers for Disease Control and Prevention (CDC), one of the foremost experts in Clostridioides difficile (C. difficile) epidemiology.
OpenBiome Foundation Launches First Free Fecal Microbiome Therapeutics (FMT) & Stool Banking Kit for Clinicians and Researchers
The OpenBiome Foundation today announced the launch of the Fecal Microbiome Therapeutics (FMT) & Stool Banking Toolkit.
Q&A with Michael Bougas, Program Director at the OpenBiome Foundation
OpenDialog October 2026 – Issue Four
This month’s OpenDialog features OpenBiome Foundation’s Program Director Michael Bougas. An eight -year veteran of the Foundation, he supports healthcare partners treating C. Difficile infections (C.diff) and advances the organization’s work in microbiome-based therapeutics. Mike focuses on ensuring partners have access to the tools and materials they need to care for patients, while continuously improving the behind-the-scenes systems that support them.
Policy Outlook: Building a microbiome-informed approach to agri-food systems and childhood nutrition policies
Fecal Microbiota Transplantation: An Introduction to FMT, its History, and Therapeutic Potential
Drugs From Bugs: Why Gates, Zuck And Benioff Think The Next Blockbusters Will Come From Inside Your Gut
FMT Update & Future Directions
Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection
Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children
Efficacy of Fecal Microbiota Transplantation: Current Evidence on Clinical Cure for FMT for the Treatment of Recurrent C. difficile Infection
